NL-OMON25201尚未招募不适用
Severe Haemophilia: Prophylactic treatment in the 2nd and 3rd decade.
niversity Medical Center Utrecht (UMC Utrecht)0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Severe haemophilia A (factor VIII < 0.01 IU/ml);
- •2. Born between January 1st 1970 and January 1st 1988;
排除标准
- •1. History of inhibitory activity of more than 5 BU at any time or less than 5 BU for more than one year;
- •2. Inadequate access to treatment during the first years of life (i.e. no access to unlimited replacement therapy during the first 4 years of life, e.g. in case of immigration);
研究者
相似试验
终止
不适用
Individually Tailored Prophylaxis in Patients With Severe Hemophilia AHemophilia ANCT00995046Hospices Civils de Lyon5
Unknown
不适用
Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in TaiwanHemophiliaNCT02908243Taiwan Society of Thrombosis and Hemostasis350
Unknown
不适用
Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation DeficienciesHealth Services AccessibilityBlood Coagulation Factor DeficienciesNCT04775888RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône500
招募中
不适用
Home treatment for haemophilia patients.haemophilia, Home treatment, prophylaxis, intravenous infusion, learningprocess.NL-OMON19959niversity Medical Centre UtrechtHeidelberglaan 100, PO box 85500 3508 GA Utrecht, the Netherlands175
招募中
1 期
ASC618 Gene Therapy in Hemophilia A PatientsHemophilia ANCT04676048ASC Therapeutics12